The First tetrafluorinated azobenzene-imidazolium ionic conjugates as potential thermotropic liquid crystalline drugs: Self-assembly properties and cytotoxic effects
No Thumbnail Available
Date
2022-01-21
Authors
Babamale, Halimah Funmilayo
Khor, Boon-Keat
Chear, Nelson Jeng-yeou
Haque, Rosenani A
Yam, WanSinn
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
A new series of tetrafluorinated azobenzene-imidazolium ionic liquid crystals (ILCs) of varying alkyl chain
length (n = 10–18 in even parity) in the imidazolium cationic head group was prepared and characterized using FTIR and NMR spectroscopy, and elemental microanalysis. Their thermal and phase properties
were investigated using differential scanning calorimetry (DSC) and polarized optical microscope (POM).
Their phase properties and morphology were influenced by fluorination and alkyl chain length. Long alkyl
chains were necessary to induce liquid crystalline behaviour in these salts. All homologues were mesogenic, exhibiting stable smectic A phase with broad temperature range. Cytotoxic effects of these ILCs
against human cervical cancer (HeLa) cells and normal fibroblasts was evaluated using the MTT assay.
Cytotoxicity of these ILCs was dependent on the alkyl chain length in the imidazolium cationic head. All
the salts were less toxic towards normal fibroblasts and exhibited 7–27-fold enhancement in cytotoxicity
against HeLa cells (24hr IC50 ranged between 0.61 μM -2.84 μM) as compared to the standard therapeutic drug, Etoposide (IC50 = 25.67 μM). Long homologues (n = 16, 18) were selective towards cancer cells
with selectivity index ≥ 3. These thermotropic ILCs could be doped with room-temperature mesomorphous polymers for the formulation of safe and selective anticancer drugs
Description
Keywords
Tetrafluorinated azobenzene-imidazolium, Ionic liquid crystals, Cytotoxicity